FABRY DISEASE GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited   
The Fabry Disease Gene Panel by NGS from Metropolis Healthcare focuses on detecting mutations in the GLA gene responsible for Fabry disease, a lysosomal storage disorder. This advanced sequencing test helps identify the genetic cause of symptoms like neuropathic pain, kidney issues, and cardiac abnormalities. Metropolis Healthcare uses high-precision technology to ensure accurate variant detection. The results support early diagnosis, risk assessment, and personalized clinical management 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 19,950.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: G0110

Frequently Asked Questions (FAQ's):

What is the Fabry Disease Gene Panel?
This test analyzes the GLA gene using next-generation sequencing at Metropolis Healthcare to detect mutations linked to Fabry disease.

Why is this test important?
It helps confirm the genetic cause of symptoms such as burning limb pain, kidney dysfunction, or heart involvement.

Which sample type is needed for the test?
EDTA blood is required for DNA extraction and sequencing.

How does Metropolis Healthcare perform this test?
Using high-quality NGS technology, Metropolis Healthcare accurately identifies pathogenic variants in the GLA gene.

Who should consider taking this test?
Individuals with suspected Fabry disease or a family history of the condition.

How long does it take to receive results?
The report is provided within the standard NGS processing timeline at Metropolis Healthcare.

Can this test guide treatment?
Yes, identifying the specific mutation helps clinicians plan enzyme replacement or targeted therapy.

Is genetic counselling recommended?

Genetic counselling is advised to understand inheritance patterns and implications for family members 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab